Literature DB >> 11914619

Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study.

A M Shaaban1, J P Sloane, C R West, F R Moore, C Jarvis, E M I Williams, C S Foster.   

Abstract

The hypothetical multistep model of carcinogenesis indicates that breast cancer develops via a series of intermediate hyperplastic lesions through in situ to invasive carcinoma. To identify the risk inherent within the different morphologic lesions, we have analyzed the data from 674 benign biopsy specimens comprising 120 cases who subsequently developed breast cancer and 382 controls (matched for age and date of biopsy) spanning a period up to 20 years of follow-up (mean 66.95 months). In this series we have confirmed an increased risk associated with certain types of benign breast lesions. Atypical lobular hyperplasia was the most significant risk factor for breast cancer with more unfavorable outcome in patients <50 years of age (p = 0.003) and a relative risk (RR) of 4.55 (confidence interval [CI] 1.77-11.69). Hyperplasia of usual type showed an RR of 1.53 (CL 1.10-2.13) with a statistically worse probability of survival (cancer-free time) for patients >50 years. For atypical ductal hyperplasia the RR was 2.03 (CI 0.80-1.39). Blunt duct adenosis was significantly more common in cases progressing to breast cancer compared with controls, showing an RR of 2.08 (CI 1.12-2.85). We describe in detail the criteria of morphologic changes observed in blunt duct adenosis and define, for the first time, the level of risk associated with each of its six subtypes. Improved knowledge of breast carcinogenesis will provide insight for defining high-risk groups thus resulting in improved screening and management regimens.

Entities:  

Mesh:

Year:  2002        PMID: 11914619     DOI: 10.1097/00000478-200204000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  27 in total

1.  Proliferating activity in columnar cell lesions of the breast.

Authors:  Jean-Christophe Noel; Isabelle Fayt; Sergio Fernandez-Aguilar; Frederic Buxant; Rachel Boutemy
Journal:  Virchows Arch       Date:  2006-10-06       Impact factor: 4.064

2.  Alterations of gene expression in the development of early hyperplastic precursors of breast cancer.

Authors:  Sangjun Lee; Dan Medina; Anna Tsimelzon; Syed K Mohsin; Sufeng Mao; Yun Wu; D Craig Allred
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

3.  [Flat epithelial neoplasia and other columnar cell lesions of the breast].

Authors:  F R Fritzsche; M Dietel; G Kristiansen
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

4.  B3 breast lesions determined by vacuum-assisted biopsy: how to reduce the frequency of benign excision biopsies.

Authors:  M Tonegutti; V Girardi; S Ciatto; E Manfrin; F Bonetti
Journal:  Radiol Med       Date:  2010-09-17       Impact factor: 3.469

5.  Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort.

Authors:  Nur Zeinomar; Kelly-Anne Phillips; Mary B Daly; Roger L Milne; Gillian S Dite; Robert J MacInnis; Yuyan Liao; Rebecca D Kehm; Julia A Knight; Melissa C Southey; Wendy K Chung; Graham G Giles; Sue-Anne McLachlan; Michael L Friedlander; Prue C Weideman; Gord Glendon; Stephanie Nesci; Irene L Andrulis; Saundra S Buys; Esther M John; John L Hopper; Mary Beth Terry
Journal:  Int J Cancer       Date:  2019-02-20       Impact factor: 7.396

6.  Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.

Authors:  Min Yi; Funda Meric-Bernstam; Lavinia P Middleton; Banu K Arun; Isabelle Bedrosian; Gildy V Babiera; Rosa F Hwang; Henry M Kuerer; Wei Yang; Kelly K Hunt
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

7.  A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.

Authors:  Geoffrey C Kabat; Joan G Jones; Neal Olson; Abdissa Negassa; Catherine Duggan; Mindy Ginsberg; Rita A Kandel; Andrew G Glass; Thomas E Rohan
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

8.  Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.

Authors:  Sarah A Aroner; Laura C Collins; Stuart J Schnitt; James L Connolly; Graham A Colditz; Rulla M Tamimi
Journal:  Breast Cancer Res       Date:  2010-08-06       Impact factor: 6.466

9.  Benign breast disease heterogeneity: association with histopathology, age, and ethnicity.

Authors:  Jingfang Cheng; Shijing Qiu; Usha Raju; Sandra R Wolman; Maria J Worsham
Journal:  Breast Cancer Res Treat       Date:  2007-10-05       Impact factor: 4.872

10.  Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.

Authors:  Laura C Collins; Sarah A Aroner; James L Connolly; Graham A Colditz; Stuart J Schnitt; Rulla M Tamimi
Journal:  Cancer       Date:  2015-11-13       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.